Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Current therapeutic approaches to cryptosporidiosis in immunocompromised patientsA I HoepelmanFEMS Immunology and Medical Microbiology|November 27, 1999
Immune dysfunction in patients with diabetes mellitus (DM)S E Geerlings, A I HoepelmanInfection and Immunity|May 1, 1992
Consequences of microbial attachment: directing host cell functions with adhesinsA I Hoepelman, E I TuomanenAntimicrobial Agents and Chemotherapy|March 1, 1990
Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infectionsM J Wolfhagen, A I Hoepelman, J VerhoefClinical and Diagnostic Laboratory Immunology|January 10, 1998
Influence of different conditions on kinetics of tumor necrosis factor alpha release by peripheral blood mononuclear cells after stimulation with Cryptococcus neoformans: a possible explanation for different resultsW Chaka, A F Verheul, A I HoepelmanAntimicrobial Agents and Chemotherapy|April 1, 1988
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infectionsA I Hoepelman, L J Bakker, J VerhoefThe Journal of Antimicrobial Chemotherapy|December 31, 1997
Cross-protection by anti-core glycolipid antibodies: evidence from animal experimentsW N Hustinx, K Kraaijeveld, A I Hoepelman, et al.The Journal of Antimicrobial Chemotherapy|August 1, 1996
Issues in the adjunct therapy of severe sepsisJ Verhoef, W M Hustinx, H Frasa, et al.The Netherlands Journal of Medicine|July 4, 1998
Primary oligoarthritis in a parent of a child with meningococcal group B sepsis and meningitisV Bongers, A A Blaauw, J W Bijlsma, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2000
Is a second urine specimen necessary for the diagnosis of asymptomatic bacteriuria?S E Geerlings, E C Brouwer, W Gaastra, et al.Pageof 6